アデノシンキナーゼとADALは,変化したアデノシンの解毒を調整し,代謝を保ちます
Akiko Ogawa1, Satoshi Watanabe2, Iuliia Ozerova3
1Department of Modomics Biology and Medicine, Institute of Development, Aging and Cancer (IDAC), Tohoku University, Sendai 980-8575, Japan; Department of Modomics Pharmacology, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai 980-8578, Japan.
Cell
|August 21, 2025
まとめ
細胞は,配列代謝経路を通じてRNA分解から細胞毒性改変核酸化物を解毒する. このプロセスにはアデノシンキナーゼ (ADK) とアデノシンデアミナーゼ (ADAL) が含まれており,N6型アデノシンモノフォスファートの蓄積と関連する代謝障害を防ぐことができます.
科学分野:
- 分子生物学
- RNA メタボリズム
- 生物化学
背景:
- RNAには様々な転写後の改変が含まれており,これは解剖分解時に改変した核酸に繋がります.
- これらの改造された核酸の処理と解毒のメカニズムはほとんど不明です.
- N6-メチラデノシン (m6A) のような一部の改変した核酸は,適切に処理されない場合,細胞毒性がある.
研究 の 目的:
- N6-メチラデノシン (m6A),N6-ジメチラデノシン (m6,6A),およびN6-イソペンテニラデノシン (i6A) の3つのRNA由来変異アデノシンの解毒のための代謝経路を解明する.
- 変異したアデノシン代謝の生理学的結果を in vivo で調査する.
- 変異RNA代謝の欠陥と人間の病気を関連付けるため
主な方法:
- 変異したアデノシンの in vitro と in vivo の代謝分析
- アデノシンキナーゼ (ADK) とアデノシンデアミナーゼのような (ADAL) ノックアウトマウスモデルの生成と分析.
- 酵素活性とアロステル抑制を評価する生化学的測定法
- 細胞測定は,リソソーム機能と脂質代謝を評価する.
主要な成果:
- m6A,m6,6A,およびi6Aは,ADKによるリン酸化およびADALによる脱アミネーションを経て,イノシンモノリン酸 (IMP) に順次代謝される.
- アダルのノックアウトマウスは,N6-改変アデノシンモノフォスファート (AMP) の蓄積を示し,AMP活性化タンパク質キナーゼ (AMPK) のアロステリック阻害とグルコース代謝の調節不良を引き起こします.
- ADK欠乏症はこれらの変異性アデノシンを増加させ,マウスの早期死亡を引き起こします.
- 過剰な修飾されたアデノシンはリソソームの機能を低下させ,脂質代謝を妨害し,細胞毒性を引き起こします.
結論:
- 細胞は,RNAから派生した細胞毒性改変アデノシンを排毒するための特定のヌクレオチド代謝経路を有している.
- ADKまたはADALの欠陥によるこの経路の調節不良は,重度の代謝障害と細胞毒性につながる.
- この研究は,改変されたRNA代謝,核酸処理,およびヒトが受け継いだピューリン代謝の障害との間の重要な関連性を確立している.
関連する概念動画
01:19Allosteric Proteins-ATCase
5.9K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.9K
01:28Biosynthesis of Nucleic Acids
169
Nucleic acid biosynthesis is a fundamental biochemical process that produces the purine and pyrimidine nucleotides essential for DNA and RNA synthesis. This pathway maintains a balanced nucleotide pool, preventing imbalances that could jeopardize genetic integrity and cellular function. Given the crucial role of nucleotides, their synthesis is tightly regulated to ensure proper cellular homeostasis.Purine BiosynthesisThe biosynthesis of purine nucleotides begins with ribose-5-phosphate, a...
169
01:26Enhanced Elimination of Poison
577
Poison can be effectively removed from the gastrointestinal (GI) tract through various decontamination procedures.
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
577
01:17Antidotes
756
Antidotes are medicinal substances used to counteract the harmful effects of toxins or drugs in the body. They function in various ways, each uniquely designed to combat specific toxic compounds.
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
756
01:14Drug Metabolism: Phase II Reactions
4.1K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
4.1K
01:19Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems
331
Phase I biotransformation reactions are integral to drug metabolism, predominantly involving oxidative, reductive, and hydrolytic transformations. Chief among these are oxidative reactions, which enhance the hydrophilicity of xenobiotics and introduce polar functional groups to facilitate their elimination from the body.
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
331